APA (7th ed.) Citation

Menne, J., Ritz, E., Ruilope, L. M., Chatzikyrkou, C., Viberti, G., & Haller, H. (2014). The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow‐up study: Benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation. Journal of the American Heart Association, 3(2), . https://doi.org/10.1161/JAHA.114.000810

Chicago Style (17th ed.) Citation

Menne, Jan, Eberhard Ritz, Luis M. Ruilope, Christos Chatzikyrkou, Giancarlo Viberti, and Hermann Haller. "The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐up Study: Benefits of RAS Blockade with Olmesartan Treatment Are Sustained After Study Discontinuation." Journal of the American Heart Association 3, no. 2 (2014). https://doi.org/10.1161/JAHA.114.000810.

MLA (9th ed.) Citation

Menne, Jan, et al. "The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐up Study: Benefits of RAS Blockade with Olmesartan Treatment Are Sustained After Study Discontinuation." Journal of the American Heart Association, vol. 3, no. 2, 2014, https://doi.org/10.1161/JAHA.114.000810.